Search for: "Teva Pharmaceuticals"
Results 1001 - 1020
of 1,430
Sort by Relevance
|
Sort by Date
3 Nov 2010, 7:00 am
Teva Pharmaceutical Industries Ltd. followed the same year. [read post]
3 Nov 2010, 5:56 am
" Teva Pharmaceutical Indus. [read post]
3 Nov 2010, 5:10 am
Teva Pharmaceuticals USA, Inc., 518 F.3d 1353 (Fed. [read post]
3 Nov 2010, 1:21 am
No – discussion of patent-eligibility standards for genes (Patent Baristas) US: Appellees file reply brief in Therasense v Becton Dickinson (Patent Docs) US: Another Capitol Hill missive objects to the inclusion of patent settlement provisions in FY 2011 Appropriations Bill (FDA Law Blog) US: REMS and 180-day exclusivity forfeiture – some interesting disclosures to the SEC (FDA Law Blog) Products Botox (Botulinum) – EU: General Court upholds opposition to BOTUMAX Community… [read post]
2 Nov 2010, 10:26 am
Teva Pharmaceuticals, 395 F.3d 1364, 1370, 1379 (Fed. [read post]
31 Oct 2010, 7:00 am
Donahue On November 1, Gary Buehler, the longtime director of FDA's Office of Generic Drugs (OGD), is joining Teva Pharmaceutical Industries Ltd. as Vice President of Regulatory Strategic Operations. [read post]
29 Oct 2010, 4:32 pm
9/15/2010 Unlawful marketing - Levothroid and promoting Celexa and Lexapro for pediatric use Elan Corporation - $203.5 M - 7/15/2010 - improper marketing of Zonegran Teva Pharmaceuticals - $169 M - 7/26/2010 - Inflated prices reported to Medicaid WellCare Health Plans - $137.5 M- 8/9/2010 - Defrauded Medicare and Medicaid programs in several… [read post]
27 Oct 2010, 12:17 pm
Yohn Jr. in Teva v. [read post]
27 Oct 2010, 8:57 am
Other companies in the top 10 include Novartis Pharmaceuticals, Forest Laboratories and Teva Pharmaceuticals. [read post]
27 Oct 2010, 8:57 am
Other companies in the top 10 include Novartis Pharmaceuticals, Forest Laboratories and Teva Pharmaceuticals. [read post]
19 Oct 2010, 10:42 pm
General WTO paragraph 6 meeting aims at improved use of health waiver (IP Watch) The absence of investment in new antibiotics (IPBiz) Integration of intellectual property and regulatory exclusivity strategies for life science companies (IP Spotlight) Pharmaceutical companies can innovate if they want to (profitability through simplicity) Medicines Patent Pool seeks business director (IP Watch) WHO moves IP, innovation out of Director General’s office (IP Watch) A rights-poor… [read post]
12 Oct 2010, 9:59 pm
§ 2201) in the Hatch-Waxman context in Teva Pharmaceuticals USA, Inc. v. [read post]
12 Oct 2010, 8:56 pm
Highlights this week included: Aricept(Donepezil) –US: Declaratory judgment jurisdiction for subsequent Paragraph IV filers: Teva Pharmaceuticals USA, Inc. v. [read post]
8 Oct 2010, 3:22 pm
Malkin On September 30, Teva Pharmaceutical Industries Ltd. [read post]
6 Oct 2010, 11:43 pm
Teva appealed the decision arguing that the case should proceed, and the Federal Circuit agreed applying a 2008 decision in Caraco Pharmaceutical Laboratories, Ltd. v. [read post]
6 Oct 2010, 4:31 pm
By Jason RantanenTeva Pharmaceuticals USA, Inc. v. [read post]
30 Sep 2010, 11:44 am
Teva, Cisco, and the Generic Pharma Association: The current standard creates an incentive for patent applicants to conceal material information from the USPTO. [read post]
29 Sep 2010, 12:44 pm
, Inc.Amicus brief for Teva Pharmaceuticals, et al.Amicus brief for Securities Industry and Financial Markets Association, et al.Amicus brief for IntelAmicus brief for Facebook Inc., et al.Amicus brief for Electronic Frontier Foundation, et al.Amicus brief for CTIA - The Wireless AssociationAmicus brief for Apple Inc.Amicus brief for Acushnet, et al.Amicus brief for 36 Professors Today’s second petition of the day is: Title: Hall v. [read post]
29 Sep 2010, 8:28 am
Teva Pharmaceuticals USA, Inc., C.A. [read post]
28 Sep 2010, 3:14 pm
Teva Pharmaceuticals USA Inc. et al. [read post]
